Erin Brady is an experienced professional in pharmaceutical and biotech development and commercialization, focused on driving intelligent, data-driven investment decisions to enhance healthcare for patients globally. They have held various leadership positions at Roche, including Partnering Commercial Assessment Lead and Disease Area Leader in Neurology, where they provided strategic insights and oversaw commercialization efforts. Erin also served as a Senior Research Analyst at Innovation Dynamics and a Healthcare Analyst at Datamonitor, where they specialized in market research and competitive intelligence. They hold a Bachelor of Science with First Class Honours in Biotechnology and Biochemistry and a Bachelor of Business in Management and Marketing from Swinburne University of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices